81 related articles for article (PubMed ID: 31392083)
1. Prolactin-inducible EDD E3 ubiquitin ligase promotes TORC1 signalling, anti-apoptotic protein expression, and drug resistance in breast cancer cells.
MacDonald TM; Thomas LN; Daze E; Marignani P; Barnes PJ; Too CK
Am J Cancer Res; 2019; 9(7):1484-1503. PubMed ID: 31392083
[TBL] [Abstract][Full Text] [Related]
2. Prolactin and androgen R1881 induce pro-survival carboxypeptidase-D and EDD E3 ligase in triple-negative and HER2+ breast cancer.
MacDonald TM; Thomas LN; Gupta A; Barnes PJ; Too CK
Am J Cancer Res; 2020; 10(5):1321-1343. PubMed ID: 32509382
[TBL] [Abstract][Full Text] [Related]
3. Progestin-inducible EDD E3 ubiquitin ligase binds to α4 phosphoprotein to regulate ubiquitination and degradation of protein phosphatase PP2Ac.
McDonald WJ; Thomas LN; Koirala S; Too CKL
Mol Cell Endocrinol; 2014 Jan; 382(1):254-261. PubMed ID: 24145130
[TBL] [Abstract][Full Text] [Related]
4. alpha4 phosphoprotein interacts with EDD E3 ubiquitin ligase and poly(A)-binding protein.
McDonald WJ; Sangster SM; Moffat LD; Henderson MJ; Too CK
J Cell Biochem; 2010 Aug; 110(5):1123-9. PubMed ID: 20544796
[TBL] [Abstract][Full Text] [Related]
5. Prolactin/androgen-inducible carboxypeptidase-D increases with nitrotyrosine and Ki67 for breast cancer progression in vivo, and upregulates progression markers VEGF-C and Runx2 in vitro.
Thomas LN; Chedrawe ER; Barnes PJ; Too CKL
Breast Cancer Res Treat; 2017 Jul; 164(1):27-40. PubMed ID: 28364216
[TBL] [Abstract][Full Text] [Related]
6. ITCH-dependent proteasomal degradation of c-FLIP induced by the anti-HER3 antibody 9F7-F11 promotes DR5/caspase 8-mediated apoptosis of tumor cells.
Le Clorennec C; Lazrek Y; Dubreuil O; Sampaio C; Larbouret C; Lanotte R; Poul MA; Barret JM; Prost JF; Pèlegrin A; Chardès T
Cell Commun Signal; 2019 Aug; 17(1):106. PubMed ID: 31443721
[TBL] [Abstract][Full Text] [Related]
7. Prolactin activates mammalian target-of-rapamycin through phosphatidylinositol 3-kinase and stimulates phosphorylation of p70S6K and 4E-binding protein-1 in lymphoma cells.
Bishop JD; Nien WL; Dauphinee SM; Too CK
J Endocrinol; 2006 Aug; 190(2):307-12. PubMed ID: 16899564
[TBL] [Abstract][Full Text] [Related]
8. Mucuna pruriens (L.) DC chemo sensitize human breast cancer cells via downregulation of prolactin-mediated JAK2/STAT5A signaling.
Sinha S; Sharma S; Vora J; Shah H; Srivastava A; Shrivastava N
J Ethnopharmacol; 2018 May; 217():23-35. PubMed ID: 29427634
[TBL] [Abstract][Full Text] [Related]
9. Compound A attenuates toll-like receptor 4-mediated paclitaxel resistance in breast cancer and melanoma through suppression of IL-8.
Sootichote R; Thuwajit P; Singsuksawat E; Warnnissorn M; Yenchitsomanus PT; Ithimakin S; Chantharasamee J; Thuwajit C
BMC Cancer; 2018 Feb; 18(1):231. PubMed ID: 29486738
[TBL] [Abstract][Full Text] [Related]
10. Acyl-CoA synthetase-4 is implicated in drug resistance in breast cancer cell lines involving the regulation of energy-dependent transporter expression.
Orlando UD; Castillo AF; Medrano MAR; Solano AR; Maloberti PM; Podesta EJ
Biochem Pharmacol; 2019 Jan; 159():52-63. PubMed ID: 30414939
[TBL] [Abstract][Full Text] [Related]
11. E3 ubiquitin ligase isolated by differential display regulates cervical cancer growth
Li J; Wang X; Zhang Y; Zhang Y
Exp Ther Med; 2016 Aug; 12(2):676-682. PubMed ID: 27446260
[TBL] [Abstract][Full Text] [Related]
12. The investigational Aurora kinase A inhibitor alisertib (MLN8237) induces cell cycle G2/M arrest, apoptosis, and autophagy via p38 MAPK and Akt/mTOR signaling pathways in human breast cancer cells.
Li JP; Yang YX; Liu QL; Pan ST; He ZX; Zhang X; Yang T; Chen XW; Wang D; Qiu JX; Zhou SF
Drug Des Devel Ther; 2015; 9():1627-52. PubMed ID: 25834401
[TBL] [Abstract][Full Text] [Related]
13. GPER promotes tamoxifen-resistance in ER+ breast cancer cells by reduced Bim proteins through MAPK/Erk-TRIM2 signaling axis.
Yin H; Zhu Q; Liu M; Tu G; Li Q; Yuan J; Wen S; Yang G
Int J Oncol; 2017 Oct; 51(4):1191-1198. PubMed ID: 28902352
[TBL] [Abstract][Full Text] [Related]
14. Activated Wnt/β-Catenin signaling contributes to E3 ubiquitin ligase EDD-conferred docetaxel resistance in prostate cancer.
Bian P; Dou Z; Jia Z; Li W; Pan D
Life Sci; 2020 Aug; 254():116816. PubMed ID: 31472148
[TBL] [Abstract][Full Text] [Related]
15. Downregulation of the proapoptotic protein MOAP-1 by the UBR5 ubiquitin ligase and its role in ovarian cancer resistance to cisplatin.
Matsuura K; Huang NJ; Cocce K; Zhang L; Kornbluth S
Oncogene; 2017 Mar; 36(12):1698-1706. PubMed ID: 27721409
[TBL] [Abstract][Full Text] [Related]
16. Implication of alpha4 phosphoprotein and the rapamycin-sensitive mammalian target-of-rapamycin pathway in prolactin receptor signalling.
Boudreau RT; Sangster SM; Johnson LM; Dauphinee S; Li AW; Too CK
J Endocrinol; 2002 Jun; 173(3):493-506. PubMed ID: 12065239
[TBL] [Abstract][Full Text] [Related]
17. AMPK Activation of Apoptotic Markers in Human Breast Cancer Cell Lines with Different p53 Backgrounds: MCF-7, MDA-MB-231 and T47D Cells.
El-Masry OS; Brown BL; Dobson PRM
Asian Pac J Cancer Prev; 2019 Dec; 20(12):3763-3770. PubMed ID: 31870119
[TBL] [Abstract][Full Text] [Related]
18. Progressive resistance to apoptosis in a cell lineage model of human proliferative breast disease.
Starcevic SL; Elferink C; Novak RF
J Natl Cancer Inst; 2001 May; 93(10):776-82. PubMed ID: 11353788
[TBL] [Abstract][Full Text] [Related]
19. Synergy of leptin/STAT3 with HER2 receptor induces tamoxifen resistance in breast cancer cells through regulation of apoptosis-related genes.
Papanikolaou V; Stefanou N; Dubos S; Papathanasiou I; Palianopoulou M; Valiakou V; Tsezou A
Cell Oncol (Dordr); 2015 Apr; 38(2):155-64. PubMed ID: 25539992
[TBL] [Abstract][Full Text] [Related]
20. Overexpression of the mTOR alpha4 phosphoprotein activates protein phosphatase 2A and increases Stat1alpha binding to PIAS1.
Nien WL; Dauphinee SM; Moffat LD; Too CK
Mol Cell Endocrinol; 2007 Jan; 263(1-2):10-7. PubMed ID: 17084018
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
